BCHE and Alzheimer disease: However, only six drugs have been applied clinically for AD treatment, including four cholinesterase inhibitors (Marucci et al., 2021), one N-methyl-D-aspartate (NMDA) receptor antagonist, and one sodium oligomannate that remodels the gut microbiota and suppresses neuroinflammation (Wang et al., 2019).